PDS Biotechnology Corp Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
PDS Biotechnology Corp (PDSB) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $11.80 million as of 2021-12-31, per its 10-K filed 2022-03-31.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2022-03-31
- 2021-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $11.80M.
- 2020-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $1.32M.
- 2020-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $1.42M.
- 2020-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $1.55M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2021-12-31 | $11.80M 10-K · filed 2022-03-31 |
| 2020-12-31 | $1.32M 10-K · filed 2021-03-18 |
| 2020-09-30 | $1.42M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $1.55M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $1.57M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $1.68M 10-K · filed 2020-03-27 |
| 2019-09-30 | $1.75M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $1.94M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-14 |
| 2018-12-31 | $8.73M 10-K · filed 2019-02-21 |
| 2018-09-30 | $13.29M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $15.32M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $22.74M 10-Q · filed 2018-05-01 |
| 2017-12-31 | $12.97M 10-K · filed 2018-03-01 |
| 2017-09-30 | $13.55M 10-Q · filed 2017-11-01 |
| 2017-06-30 | $14.64M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $15.29M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $10.08M 10-K · filed 2017-03-02 |
| 2016-09-30 | $10.35M 10-Q · filed 2016-11-01 |
| 2016-06-30 | $10.95M 10-Q · filed 2016-08-03 |
| 2016-03-31 | $11.86M 10-Q · filed 2016-05-03 |
| 2015-12-31 | $9.38M 10-K · filed 2016-03-08 |
| 2015-09-30 | $9.85M 10-Q · filed 2015-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |